Apamistamab
Term · Oncology and biomedicine · MLC-T-ONC-011193
A murine IgG1 anti-CD45 monoclonal antibody (MoAb) with immunotherapeutic activity. CD45 antigen, a receptor protein-tyrosine phosphatase essential for T cell development and lymphocyte activation, is expressed on virtually all leukocytes. Apamistamab has specificity for hematopoietic tissues and may be used in targeted immunotherapy.
| Identifier | MLC-T-ONC-011193 |
|---|---|
| Field | Oncology and biomedicine |
| Synonyms | anti-CD45 monoclonal antibody BC8; monoclonal antibody BC8 |
| References | National Cancer Institute Thesaurus (CC BY 4.0) |
Record as JSON
{
"id": "MLC-T-ONC-011193",
"term": "Apamistamab",
"field": "Oncology and biomedicine",
"definition": "A murine IgG1 anti-CD45 monoclonal antibody (MoAb) with immunotherapeutic activity. CD45 antigen, a receptor protein-tyrosine phosphatase essential for T cell development and lymphocyte activation, is expressed on virtually all leukocytes. Apamistamab has specificity for hematopoietic tissues and may be used in targeted immunotherapy.",
"synonyms": [
"anti-CD45 monoclonal antibody BC8",
"monoclonal antibody BC8"
],
"references": [
"National Cancer Institute Thesaurus"
],
"url": "https://mlchart.com/terminology/oncology/apamistamab/"
}
Record 2,358 of 17,717 in Oncology and biomedicine terminology (MLC-0111). Request the full dataset.